Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FR.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FR.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
MH.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
LB.1.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
KP.3.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.81EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBL.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCDEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XCDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.44.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.44.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.45.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.45.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.273EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.273EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.13 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.4.13 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.358EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.358EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.60EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.159EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used